BiotechTube

BG9418 (interferon beta-1a)

Pre-clinicalCompleted
0 watching 0 views this week💤 Quiet
20
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Prenatal Exposure Delayed Effects

Conditions

Prenatal Exposure Delayed Effects, Multiple Sclerosis, Pregnancy

Trial Timeline

Feb 1, 2004 → Sep 1, 2011

NCT ID
NCT00168714

About BG9418 (interferon beta-1a)

BG9418 (interferon beta-1a) is a pre-clinical stage product being developed by Biogen for Prenatal Exposure Delayed Effects. The current trial status is completed. This product is registered under clinical trial identifier NCT00168714. Target conditions include Prenatal Exposure Delayed Effects, Multiple Sclerosis, Pregnancy.

Hype Score Breakdown

Clinical
5
Activity
2
Company
7
Novelty
2
Community
1

Clinical Trials (2)

NCT IDPhaseStatus
NCT00828204Phase 3Completed
NCT00168714Pre-clinicalCompleted

Other Products from Biogen

Interferon-beta-1a + methylprednisoloneApproved
82
Dimethyl fumarateApproved
82
[18F]Florbetapir PET imagingApproved
82
dimethyl fumarateApproved
82
ibritumomab tiuxetan (Zevalin®)Approved
82